Ciliary G-Protein Coupled Receptor Signaling in Polycystic Kidney Disease
Open Access
- 22 May 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (11) , 4971
Abstract
Polycystic kidney disease (PKD), a ciliopathy caused primarily by mutations in the Pkd1 and Pkd2 genes, disrupts renal structure and function, leading to progressive renal failure. The primary cilium, a sensory organelle essential for cellular signaling, plays a pivotal role in maintaining renal function. Among its signaling components, G-protein-coupled receptors (GPCRs) within the cilium have gained significant attention for their localized functions and their contribution to PKD pathogenesis. Dysfunction of ciliary GPCR signaling alters key downstream pathways, including mammalian target of rapamycin (mTOR), cyclic adenosine monophosphate (cAMP), and calcium homeostasis, exacerbating cyst formation and disease progression. Additionally, interactions between ciliary GPCRs and PKD-associated proteins, such as Polycystin-1 (PC1) and Polycystin-2 (PC2), underline the complexity of PKD mechanisms. Recent advances highlight GPCRs as promising therapeutic targets for ciliopathies, including PKD. Emerging GPCR modulators and drugs in clinical trials show the potential to restore ciliary signaling and attenuate disease progression. This paper explores the physiological functions of ciliary GPCRs, their mechanistic links to PKD, and the therapeutic implications of targeting these receptors, offering insights into future research directions and therapeutic strategies for PKD.Keywords
Funding Information
- American Foundation of Pharmaceutical Education (AFPE) Gateway to Research Award (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
- the University of Toledo Office of Research and Sponsored Programs (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
- Alzheimer’s Association (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
- NIA (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
- NHLBI (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
This publication has 92 references indexed in Scilit:
- Crosstalk between the mTOR pathway and primary cilia in human diseases2023
- Prostaglandin signaling in ciliogenesis and developmentJournal of Cellular Physiology, 2021
- Primary Cilia in Brain Development and DiseasesThe American Journal of Pathology, 2018
- How Ligands Illuminate GPCR Molecular PharmacologyCell, 2017
- Motile and non‐motile cilia in human pathology: from function to phenotypesThe Journal of Pathology, 2016
- Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseasesHepatology, 2012
- Dopamine, the Kidney, and HypertensionCurrent Hypertension Reports, 2012
- Physiology and pathophysiology of the vasopressin-regulated renal water reabsorptionPflügers Archiv - European Journal of Physiology, 2008
- Somatostatin and α2‐adrenergic agonists selectively inhibit vasopressin‐induced cyclic AMP accumulation in MDCK cellsFEBS Letters, 1986
- Aggressive behavior and the Rosenzweig Picture-Frustration (P-F) studyJournal of Clinical Psychology, 1976